The XO inhibitor allopurinol virtually abolished the development of cardiac diastolic dysfunction and ischemia in high fructose high fat diet-induced IR in rats without affecting the developed hyperinsulinemia or dyslipidemia. This evidence concerns the gene XDH and metabolic syndrome.